Tyra Biosciences, Inc.
TYRA
$10.09
$0.020.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 25.89M | 24.13M | 21.52M | 20.30M | 18.62M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 113.73M | 104.20M | 100.09M | 95.45M | 87.93M |
| Operating Income | -113.73M | -104.20M | -100.09M | -95.45M | -87.93M |
| Income Before Tax | -96.44M | -86.48M | -83.74M | -80.88M | -75.45M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -96.44 | -86.48 | -83.74 | -80.88 | -75.45 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -96.44M | -86.48M | -83.74M | -80.88M | -75.45M |
| EBIT | -113.73M | -104.20M | -100.09M | -95.45M | -87.93M |
| EBITDA | -113.19M | -103.68M | -99.62M | -95.02M | -87.54M |
| EPS Basic | -1.63 | -1.51 | -1.61 | -1.69 | -1.68 |
| Normalized Basic EPS | -1.02 | -0.94 | -1.00 | -1.06 | -1.05 |
| EPS Diluted | -1.63 | -1.51 | -1.61 | -1.69 | -1.68 |
| Normalized Diluted EPS | -1.02 | -0.94 | -1.00 | -1.06 | -1.05 |
| Average Basic Shares Outstanding | 235.94M | 228.83M | 212.74M | 196.73M | 180.65M |
| Average Diluted Shares Outstanding | 235.94M | 228.83M | 212.74M | 196.73M | 180.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |